Avivagen Inc

Chart & Performance

D1W1MN

P/E

—

P/S

0.01

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

39.52%

Revenues

939k

-27.53%

Net income

-6m

L-5.13%

CFO

-3m

L-32.24%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

URL

https://avivagen.com/

IPO date

Mar 04, 2004

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2022‑10	2021‑10	2020‑10	2019‑10	2018‑10	2017‑10	2016‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT